CYP2E1 and Parkinson disease: We cannot explain the conflicting results of cg13315147, which might be due to different PD medication in both cohorts, but the other four CpGs also analysed by Henderson-Smith underline our finding of unchanged CYP2E1 methylation status in the peripheral blood of PD patients.